Microarray Discovery of New OGT Substrates: The Medulloblastoma Oncogene OTX2 Is O-GlcNAcylated
MetadataShow full item record
CitationOrtiz-Meoz, Rodrigo F., Yifat Merbl, Marc W. Kirschner, and Suzanne Walker. 2014. “Microarray Discovery of New OGT Substrates: The Medulloblastoma Oncogene OTX2 Is O-GlcNAcylated.” Journal of the American Chemical Society 136 (13): 4845-4848. doi:10.1021/ja500451w. http://dx.doi.org/10.1021/ja500451w.
AbstractO-GlcNAc transferase (OGT) is a serine/threonine glycosyltransferase that is essential for development and continues to be critically important throughout life. Understanding OGT’s complex biology requires identifying its substrates. Here we demonstrate the utility of a microarray approach for discovering novel OGT substrates. We also report a rapid method to validate OGT substrates that combines in vitro transcription-translation with O-GlcNAc mass tagging. Among the validated new OGT targets is Orthodenticle homeobox 2 (OTX2), a transcription factor critical for brain development, which is primarily expressed only during early embryogenesis and in medulloblastomas, where it functions as an oncogene. We show that endogenous OTX2 from a medulloblastoma cell line is O-GlcNAcylated at several sites. Our results demonstrate that protein microarray technology, combined with the target validation strategy we report, is useful for identifying biologically important OGT substrates, including substrates not present in most tissue types or cell lines.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12152955
- HMS Scholarly Articles